Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation.
about
Management of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewManagement of recurrent hepatitis C virus after liver transplantation.Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.Griffithsin has antiviral activity against hepatitis C virusBreadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjectsOutcomes for patients with HCV after liver transplantation in Korea: a multicenter studySofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation.Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin.Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrenceInterleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision MakingSpanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.New insights in recurrent HCV infection after liver transplantationA retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation.PEGYLATED INTERFERON AND RIBAVIRIN FOR TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: a single-liver transplant center experience in Brazil.Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti-CD81 monoclonal antibody.Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study.HCV in liver transplantation.Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers.Liver transplantation and hepatitis C
P2860
Q26781741-0DB58094-D3A7-455C-B4B7-062B99845476Q34589655-E60A83AC-2D93-4634-9821-D9589CE9424FQ35270256-A6F8A49E-2338-4144-B55D-6339127D5BC4Q35363633-E6E25B3C-FBAB-4FE1-8128-3DCF1D711BE1Q35557994-C3C47D24-F657-475F-9199-78891BEFA7A6Q35685409-DFAB5343-C801-4FA5-8590-D6F09116FA3FQ35808230-A2B7DFE1-D744-46A0-B389-5AFEED6D9D7DQ35980958-8A5817E2-A17A-432F-8A05-BF1A21BB3E44Q36476188-640B8B38-2118-41C6-B127-7245DD5E8A76Q36587395-A007311E-D012-49F8-BE68-AB8028E84C56Q36668891-EE6796CC-6E94-4ECF-824B-691789B45625Q36816846-85306050-E00B-4680-8861-55CD2CA6E386Q37298739-762FB5EB-E060-4366-8F6E-0B3DEFBFF0E9Q37349067-272F66AC-E989-4987-8048-0810345EC866Q37613481-1C1EE80C-1A24-4F8C-BB50-1242867B41D0Q37973516-5F12BC17-B0A7-4650-93E0-ACE1C5A4AEF9Q38109628-71C76D62-E2C7-4F28-BF48-0E7123F5A41AQ38286355-27EE396D-5745-4202-831F-437804A1B846Q38961331-FACE8EDA-E650-427C-827C-399580D1B2B0Q40943341-A7519AE7-2E3A-4119-BFE4-56FE1C50A873Q41651833-5EA585F4-7F31-43A5-AAD6-9F74571501DBQ42183060-B6667FC2-F1A2-427F-89EC-27EEA06AA5B3Q42982631-5EA9D272-843C-4143-8A16-17324F30EA94Q42991323-81244890-3293-41EB-9D3A-C417B5BB4951Q45016250-78E95A59-8414-4217-BA0D-AD19B5142FEEQ50550145-DCB1774E-2E10-46AE-BB2F-07F5490B9BEEQ58704499-B75633E5-AFE5-4917-83F6-DEED7E89020F
P2860
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Systematic review: anti-viral ...... C after liver transplantation.
@en
Systematic review: anti-viral ...... C after liver transplantation.
@nl
type
label
Systematic review: anti-viral ...... C after liver transplantation.
@en
Systematic review: anti-viral ...... C after liver transplantation.
@nl
prefLabel
Systematic review: anti-viral ...... C after liver transplantation.
@en
Systematic review: anti-viral ...... C after liver transplantation.
@nl
P2860
P1476
Systematic review: anti-viral ...... C after liver transplantation.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2010.04505.X
P407
P577
2010-11-09T00:00:00Z